412 related articles for article (PubMed ID: 18705325)
1. Oily chemoembolization combined with degradable starch microspheres for HCC with cirrhosis.
Murata S; Tajima H; Ichikawa K; Onozawa S; Wang J; Kumita S; Nomura K
Hepatogastroenterology; 2008; 55(84):1041-6. PubMed ID: 18705325
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
[TBL] [Abstract][Full Text] [Related]
3. [Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study].
Gattoni F; Cornalba G; Brambilla G; Dova S; Pompili G; Rampoldi A; Damiani G; Carnevali G; Uslenghi CM
Radiol Med; 1998 Apr; 95(4):362-8. PubMed ID: 9676217
[TBL] [Abstract][Full Text] [Related]
4. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study.
Orlacchio A; Chegai F; Roma S; Merolla S; Bosa A; Francioso S
Radiol Med; 2020 Jan; 125(1):98-106. PubMed ID: 31583558
[TBL] [Abstract][Full Text] [Related]
5. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
[TBL] [Abstract][Full Text] [Related]
6. [Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma].
Horikiri N; Yamakado K; Nakatsuka A; Ishii T; Matsushima N; Tanaka N; Takeda K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1493-6. PubMed ID: 11707962
[TBL] [Abstract][Full Text] [Related]
7. Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and Efficacy.
Gross A; Albrecht T
Cardiovasc Intervent Radiol; 2020 Mar; 43(3):402-410. PubMed ID: 31705244
[TBL] [Abstract][Full Text] [Related]
8. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
[TBL] [Abstract][Full Text] [Related]
9. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma.
Furuse J; Ishii H; Satake M; Onaya H; Nose H; Mikami S; Sakai H; Mera K; Maru Y; Yoshino M
Am J Clin Oncol; 2003 Apr; 26(2):159-64. PubMed ID: 12714888
[TBL] [Abstract][Full Text] [Related]
11. Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study.
Wiggermann P; Wohlgemuth WA; Heibl M; Vasilj A; Loss M; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2013; 53(4):337-48. PubMed ID: 22555335
[TBL] [Abstract][Full Text] [Related]
12. [Extrahepatic collateral arteries are involved in the blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization].
Li Q; Yang RJ; Zhu X; Zhu LZ; Wang MQ; Duan F
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):613-7. PubMed ID: 24314221
[TBL] [Abstract][Full Text] [Related]
13. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
14. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
15. Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation.
Ko HK; Ko GY; Yoon HK; Sung KB
Korean J Radiol; 2007; 8(4):320-7. PubMed ID: 17673843
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
[TBL] [Abstract][Full Text] [Related]
17. Degradable starch microspheres transarterial chemoembolisation (DSM-TACE) of HCC: Dynamic Contrast-Enhanced Ultrasonography (DCE-US) based evaluation of therapeutic efficacy using a novel perfusion software.
Wiggermann P; Heibl M; Niessen C; Müller-Wille R; Gössmann H; Uller W; Poschenrieder F; Schreyer AG; Wohlgemuth WA; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2012; 52(2-4):123-9. PubMed ID: 22960293
[TBL] [Abstract][Full Text] [Related]
18. Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma.
Won JY; Lee DY; Lee JT; Park SI; Kim MJ; Yoo HS; Suh SH; Park SJ
Cardiovasc Intervent Radiol; 2003; 26(2):136-40. PubMed ID: 12638036
[TBL] [Abstract][Full Text] [Related]
19. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
Seki A; Hori S
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
[TBL] [Abstract][Full Text] [Related]
20. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients.
Hayashi K; Ina H; Tezuka M; Okada Y; Irie T
Cardiovasc Intervent Radiol; 2007; 30(6):1144-55. PubMed ID: 17909884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
